Kilpatrick Townsend’s Silicon Valley-based start-up team advised the founders of Editas Medicine in the biotech start-up’s $43 million Series A Financing. In a trend setting transaction, venture firms Polaris Partners, Third Rock Ventures, Flagship Ventures and the Partners Innovation Fund invited five of the most prominent research scientists in the field of genomics from MIT, Harvard, the Howard Hughes Medical Institute and the University of California in Berkeley to form a company which they would fund. The money invested will fund the collaborative research and development by this world-class team of scientists as they seek to revolutionize the treatment of genetic disorders by developing a simple, precise and inexpensive method of ‘editing out’ abnormalities in genes in human cells.

Experience Center

Match our Experience to Your Needs

View All Case Studies

Experience Highlights

Privacy data breaches
Served as lead counsel providing advice on numerous privacy data breach matters, including data breaches involving millions of credit card numbers more
American Eagle Outfitters Inc. v. Payless Shoesource Inc.
Represented American Eagle Outfitters in asserting its trademarks and advertising motif relative to advertising and sale of AMERICAN EAGLE footwear more
Settlement of a major title insurance claim for a 54 acre development project
Served as lead counsel representing the developer of a high profile, 54 acre project in a major title insurance claim arising out of an easement more
Inter Partes Reexaminations for Interface Inc.
Representing Interface, Inc. the world’s largest designer and maker of carpet tiles, in multiple IPRs and Inter Partes Reexaminations for more